Express Pharma - Page 1414 of 2184 - Express Pharma

Supriya Lifescience receives USFDA EIR with VAI classification for Lote Parshuram facility

Off label drug use and physician liability

Lupin launches Dapagliflozin and Metformin extended-release tablets in the United States

Gandhi Automations launches high speed doors

Alfa Laval’s introduces mixproof valves

Falsified medicines directive: Don’t lose track of compliance

Mechanistic absorption modelling for extending biowaivers to BCS Class IV Compounds

SPORE is focussed on a specific organ site, such as breast or lung cancer

Sheffield scientist investigates how to stop breast cancer spreading to the bone

Let’s move this story forward

Global dermatology market set to benefit extensively from pipeline biologics

Long-acting therapies could transform HIV treatment by boosting compliance

NASH market will increase more than 40 fold by 2026